If you need more lookups,
subscriptions start at $34 USD/month.
Thomas Jaquin Location
Erding, BY, DE
Thomas Jaquin Work
2025 -now Director of In vivo Pharmacology and Discovery @
2023 -2025 Group Leader (Associate Director) Preclinical Pharmacology and Biomarker Development @
2022 -2023 Associate Director, Head of preclinical Assay Platform and In Vivo @
2021 -2022 Principal Scientist, Team Leader In Vivo and Team Leader Preclinical Assay Platform @
2021 -2021 Principal Scientist, Team Leader In Vivo @
2018 -2021 Senior Scientist, Team Leader In Vivo @
2018 -2018 Senior Scientist (Immuno-Oncology) @
2016 -2018 Research Scientist (Immuno-oncology) @
2013 -2015 Senior Research Officer @
2011 -2013 Senior Research Scientist in experimental oncology @
2011 -2011 Research associate @
2005 -2011 Research Scientist @
Thomas Jaquin Education
Queen's University Belfast
Doctor of Philosophy (Ph.D.) (Doctor of Philosophy (Ph.D.), Cancer research)
2006-2011
ENSTBB Bordeaux INP
Master of Sciences (Master of Sciences, Biotechnology)
2001-2004
Thomas Jaquin Skills
Cell Biology
ELISA
In Vivo
Western Blotting
Antibodies
Confocal Microscopy
Assay Development
Biotechnology
Cell
Immunofluorescence
Immunology
Cell Culture
Purification
Drug Discovery
Molecular Biology
Oncology
Immunohistochemistry
Sds Page
Monoclonal Antibodies
In Vitro
Cancer
Protein Expression
Protein Purification
Flow Cytometry
Thomas Jaquin Summary
Thomas Jaquin, based in Erding, BY, DE, is currently a Director of In vivo Pharmacology and Discovery at Proteinea. Thomas Jaquin brings experience from previous roles at iOmx Therapeutics AG and Pieris Pharmaceuticals. Thomas Jaquin holds a 2006 - 2011 Doctor of Philosophy (Ph.D.) in Doctor of Philosophy (Ph.D.), Cancer research @ Queen's University Belfast. With a robust skill set that includes Cell Biology, ELISA, In Vivo, Western Blotting, Antibodies and more. Thomas Jaquin has 2 emails on RocketReach.
Looking for a different Thomas Jaquin?
Find contact details for 700 million professionals.